BioSpace News Archive

Pioneering Patent Covers Novel Cancer Treatments, Achieves New Company Milestone

CEL-SCI Corporation reported financial results for the fiscal year ended September 30, 2018

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th, 2019,

NGS labs in Seoul headquarters and Bundang Precision Medicine Center become the first in Korea to receive CLIA accreditation

Astellas Pharma Inc. and Pfizer Inc. today announced that the Phase 3 ARCHES trial evaluating XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) in men with metastatic hormone-sensitive prostate cancer (mHSPC) met its primary endpoint, significantly improving radiographic progression-free survival (rPFS) versus ADT alone.

Customized Version of the iTHRIVE Plan Coming to AICR Soon!

Huge Shops forms alliance with Coffee Time’s parent company Chairman’s Brands to establish retail distribution network -

Carmell Therapeutics today announced its President and CEO, Randy Hubbell, will deliver a corporate presentation at Biotech Showcase™ 2019, on Tuesday, January 8, 2019 at 3:15 PM PST at the Hilton San Francisco Union Square in the Franciscan C ballroom.

Company adds to its partnerships with leading health systems in key markets

Company delivers soft gel capsules that are 100 percent vegan, non-GMO, Halal and Kosher certified